| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $15.3M | — | -12.1% |
| SG&A Expense | $3.7M | — | -10.5% |
| Operating Income | -$19.0M | — | +11.8% |
| Pre-tax Income | -$18.0M | — | +8.1% |
| Income Tax | -$2.2M | — | +0.0% |
| Net Income | -$18.0M | — | -3.5% |
| EPS (Basic) | -$0.34 | — | +0.0% |
| EPS (Diluted) | -$0.34 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $39.1M | +3.0% | -23.8% |
| Short-term Investments | $54.4M | -27.4% | -50.1% |
| Current Assets | $95.8M | -16.9% | -41.4% |
| Total Assets | $96.6M | -17.2% | -43.4% |
| Current Liabilities | $8.6M | -24.7% | -11.9% |
| Total Liabilities | $8.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.7M | — | -7.7% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $20.8M | — | -27.5% |
| Financing Cash Flow | $0 | — | -100.0% |
| Free Cash Flow | -$19.7M | — | -7.7% |
| -18.2% |
| Stockholders' Equity | $88.0M | -16.0% | -45.1% |